Dosing and Administration

Prescribing Information

ENTYCE® (capromorelin oral solution) is indicated for appetite stimulation in dogs.1

ENTYCE for dogs is supplied as a 30-mg/mL flavored oral solution for ease of administration.

Oral Solution

ENTYCE provides a convenient, once-daily oral solution for treating inappetence. Please reference the chart for recommended dosages.

To administer ENTYCE, the bottle should be shaken gently and then the appropriate amount of solution withdrawn using the provided syringe. The syringe should be rinsed between treatment doses.1

1.ENTYCE package insert

ENTYCE Dosing Chart

3mg/kg = 0.1 mL/kg
Recommended dose:
3mg/kg (1.4 mg/lb) body weight once daily
Weight of a DogDose
lbskgmL
52.30.2
104.50.5
156.80.7
209.10.9
2511.41.1
3013.61.4
3515.91.6
4018.21.8
4520.52.1
5022.72.3
5525.02.5
6027.32.7
6529.53.0
7031.83.2
7534.13.4
8036.43.6
8538.63.9
9040.94.1

Clinical References

Your convenient one-stop source for viewing and downloading important information.

Learn more >

In-Clinic Tools

Introducing ENTYCE to your clinic as a therapeutic solution specifically designed to stimulate appetite in dogs.

Learn more >

News

Keep current on all the latest Aratana news, upcoming conferences and other timely information.

Learn more >

IMPORTANT SAFETY INFORMATION: ENTYCE® (capromorelin oral solution) is for use in dogs only. Do not use in breeding, pregnant or lactating dogs. Use with caution in dogs with hepatic dysfunction or renal insufficiency. Adverse reactions in dogs may include diarrhea, vomiting, polydipsia, and hypersalivation. Should not be used in dogs that have a hypersensitivity to capromorelin. Please see the full Prescribing Information for more detail.

ENTYCE is Now Available

Other therapeutics from Aratana

Nocita Logo

NOCITA® (bupivacaine liposome injectable suspension)

provides post-operative pain relief for cranial cruciate ligament surgery for up to 72 hours.

Now you can be sure dogs are getting the post-surgical pain relief they need even after they leave your clinic.

IMPORTANT SAFETY INFORMATION: NOCITA® (bupivacaine liposome injectable suspension) is for use in dogs only. Do not use in dogs younger than 5 months of age, dogs used for breeding, or in pregnant or lactating dogs. Do not administer by intravenous or intra-arterial injection. Adverse reactions in dogs may include discharge from incision, incisional inflammation and vomiting. Avoid concurrent use with bupivacaine HCl, lidocaine or other amide local anesthetics. Please see the full Prescribing Information for more detail.